- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02164383
A Quit Smoking Study Using Smartphones
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Wisconsin
-
Madison, Wisconsin, Verenigde Staten, 53711
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- being age 18 or older;
- being able to read and write English;
- being willing and able to learn how to use a smartphone if they have not used one before;
- smoking 10 or more cigarettes per day for the past 6 months;
- having an expired carbon monoxide rating of 6 ppm or greater;
- not having been diagnosed with or treated for schizophrenia, psychosis or bipolar disorder in the past 10 years;
- being willing to make a quit attempt in 2 weeks;
- agreeing to attend clinic visits, receive coaching calls, and complete brief smartphone assessments;
- planning to remain in the area for at least the next 2 months;
- using the following alternative tobacco products (a pipe, full sized cigars, snuff or chew) no more than two times a week over the past month;
- being willing to stop using electronic cigarettes (e-cigarettes) for the 6 weeks they are in the study;
- not currently taking bupropion, Wellbutrin, or Zyban;
- if currently using nicotine replacement therapy or Varenicline, agreeing to use only study medication for the duration of the study;
- being willing and able to use the nicotine patch;
- never having had a serious skin reaction or other allergic reaction to the nicotine patch;
- not pregnant, trying to conceive, or nursing;
- if a woman of childbearing potential, agreeing to use or having their partner use an acceptable method of birth control during a 2 month period (1 month of nicotine patch and 1 month after). (Acceptable methods of birth control include: abstinence, condoms, diaphragm, birth control pills or injectable contraceptive [e.g., Depo-Provera], an intrauterine device, hysterectomy, tubal ligation, sterilization, vasectomy, or being more than 2 years post-menopausal.)
- Participants need to report playing video games for no more than 60 minutes a day.
- Although participants can play console games, they need to be willing to not play any mobile games for 6 weeks during the study if they are asked to do so.
- Participants need to report being willing to stay in the study even if they are not at first successful in quitting smoking.
- They need to report that they have a way to get to the clinic.
Exclusion Criteria:
- They will be excluded if in the last 4 weeks they have been hospitalized for any of the following: a stroke, heart attack, congestive heart failure, or an abnormal electrocardiogram.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Mobile Games
This arm of the project will address the following question: How effective is the following intervention? Nicotine patch plus behavioral cessation counseling with access to Mobile Games. |
4-week starter kit of nicotine patch
5 brief counseling sessions
|
|
Experimenteel: No Mobile Games
This arm of the project will address the following question: How effective is the following intervention: Nicotine patch plus behavioral cessation counseling without access to Mobile Games. |
4-week starter kit of nicotine patch
5 brief counseling sessions
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change Between Baseline Mean Cigarettes Smoked Per Day and Mean Cigarettes Smoked Per Day During the First 4 Weeks of the Quit Attempt Calculated as Percentage Change
Tijdsspanne: Cigarettes per day measured daily for the first 4 weeks of the quit attempt (starting on the target quit day) and at baseline
|
Every day participants will report the number of cigarettes they smoked that day at baseline and for the first 4 weeks of the quit attempt (starting on the target quit day) using timeline followback assessment.
This information will be used to calculate a participant's change in mean cigarettes smoked per day from baseline compared to the mean across the first 4 weeks of the quit attempt calculated as percentage change.
|
Cigarettes per day measured daily for the first 4 weeks of the quit attempt (starting on the target quit day) and at baseline
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Tanya R. Schlam, PhD, University of Wisconsin Center for Tobacco Research and Intervention
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Psychische aandoening
- Chemisch veroorzaakte aandoeningen
- Middelgerelateerde aandoeningen
- Tabaksgebruiksstoornis
- Fysiologische effecten van medicijnen
- Neurotransmitter agenten
- Moleculaire mechanismen van farmacologische werking
- Autonome agenten
- Agenten van het perifere zenuwstelsel
- Cholinerge middelen
- Ganglionische stimulerende middelen
- Nicotine-agonisten
- Cholinerge agonisten
- Nicotine
Andere studie-ID-nummers
- 2013-1606
- P50CA143188 (Subsidie/contract van de Amerikaanse NIH)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .